Close

More on ERAS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+47.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/8/23)
- Conference (9/26/2023)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Erasca, Inc (NQ:ERAS)
Delayed: 2.25 -0.11 (4.66%)
Prev. Close $2.36  
Open$2.41 
52 Wk High$ 
52 Wk Low$ 
Day High$2.52 
Day Low$2.24 
P/E N/A  
EPS$ 
Volume632,675 

Friends, Peers and Foes (?): PFE, NVS, DAWN, NOVN, IMTX (more...)

Sep 19, 2023 08:00 AM Erasca to Present at the Cantor Global Healthcare Conference
Sep 15, 2023 02:50 PM Form 144 Erasca, Inc. Filed by: Erasca Foundation
Sep 5, 2023 08:00 AM Erasca to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Aug 29, 2023 04:06 PM Form 8-K Erasca, Inc. For: Aug 29
Aug 29, 2023 08:00 AM Erasca Doses First Patient in SEACRAFT-1 Phase 1b Trial Evaluating Naporafenib Plus Trametinib in Patients with RAS Q61X Solid Tumors
Aug 15, 2023 01:41 PM Form 144 Erasca, Inc. Filed by: Erasca Foundation
Aug 10, 2023 04:14 PM Form 10-Q Erasca, Inc. For: Jun 30
Aug 10, 2023 04:07 PM Form 8-K Erasca, Inc. For: Aug 10
Aug 10, 2023 04:01 PM Erasca Reports Second Quarter 2023 Financial Results and Business Updates
Jul 17, 2023 11:54 AM Form 144 Erasca, Inc. Filed by: Erasca Foundation
View All Articles

Entities mentioned with ERAS

View All Entities